CINCINNATI, April 3 /PRNewswire-FirstCall/ -- Kendle , a leading global full-service clinical research organization (CRO), today announced it has entered into a strategic relationship with Medidata Solutions to use Medidata’s Rave(R) as an in-house Electronic Data Capture (EDC) solution to streamline the collection, cleaning and processing of clinical research data for U.S. biopharmaceutical customers. This move builds on Kendle’s existing EDC capabilities, which includes the use of Oracle Clinical(TM) RDC to meet the needs of biopharmaceutical customers in Europe.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)
“Efficient delivery of high-quality data is key to Kendle’s success as a leading provider of Biometrics services,” said Gregg Dearhammer, Vice President, Biometrics. “Our partnership with Medidata positions Kendle to stay at the forefront of the dynamic clinical data management market. It further aligns our capabilities with the trend of big pharma moving toward full EDC adoption on all studies, while also providing a flexible and user-friendly solution that allows us to offer the same services on smaller trials.”
Medidata Solutions is a provider of electronic clinical data capture, management and reporting solutions, and its Rave(R) software is currently used by more than 40 biopharmaceutical, medical device and research organizations in more than 70 countries worldwide. Through Medidata’s ASPire to Win program, Kendle will become a certified implementation and services provider of the Rave(R) software, a unified platform which has been recognized for its ability to integrate EDC with other clinical applications for better manageability. Under the non-exclusive agreement, Kendle’s Biometrics associates will be trained and certified to offer in-house EDC services including database design, programming, output to sponsors, edit checks, training and support. Data will be housed, maintained and backed up on Medidata’s secure servers.
Kendle’s Biometrics offerings include Clinical Data Management, Biostatistics and Scientific Programming services on a stand-alone basis and as part of full-service Phase II-IV clinical development contracts for customers worldwide. The company has provided Biometrics services for seven of the world’s top 10 largest biopharmaceutical organizations. Kendle has data centers in the United States, Europe, Australia and Mexico staffed by nearly 500 associates.
About Kendle
Kendle International Inc. is among the world’s leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world’s biopharmaceutical companies maximize product life cycles and grow market share. With the expertise of our nearly 2,000 associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202 or from the company’s Web site at www.kendle.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Working with companies and institutions both large and small, Medidata Solutions helps accelerate the process of safely bringing life-enhancing treatments to market -- on five continents and in more than 70 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Investors, Patty Frank, +1-513-763-1992, or Media, Lori Dorer,+1-513-345-1685, both of Kendle International Inc.
